Cargando…
Therapeutic effect of various ginsenosides on rheumatoid arthritis
BACKGROUND: Rheumatoid arthritis (RA) is an autoimmune disease which causes disability and threatens the health of humans. Therefore, it is of great significance to seek novel effective drugs for RA. It has been reported that various ginsenoside monomers are able to treat RA. However, it is still un...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145820/ https://www.ncbi.nlm.nih.gov/pubmed/34034706 http://dx.doi.org/10.1186/s12906-021-03302-5 |
_version_ | 1783697258205675520 |
---|---|
author | Zhang, Meng Ren, Hongwei Li, Kun Xie, Shengsheng Zhang, Ru Zhang, Longlong Xia, Jiaxuan Chen, Xing Li, Xilin Wang, Jianxin |
author_facet | Zhang, Meng Ren, Hongwei Li, Kun Xie, Shengsheng Zhang, Ru Zhang, Longlong Xia, Jiaxuan Chen, Xing Li, Xilin Wang, Jianxin |
author_sort | Zhang, Meng |
collection | PubMed |
description | BACKGROUND: Rheumatoid arthritis (RA) is an autoimmune disease which causes disability and threatens the health of humans. Therefore, it is of great significance to seek novel effective drugs for RA. It has been reported that various ginsenoside monomers are able to treat RA. However, it is still unclear which ginsenoside is the most effective and has the potential to be developed into an anti-RA drug. METHODS: The ginsenosides, including Rg1, Rg3, Rg5, Rb1, Rh2 and CK, were evaluated and compared for their therapeutic effect on RA. In in vitro cell studies, methotrexate (MTX) and 0.05% dimethyl sulfoxide (DMSO) was set as a positive control group and a negative control group, respectively. LPS-induced RAW264.7 cells and TNF-α-induced HUVEC cells were cultured with MTX, DMSO and six ginsenosides, respectively. Cell proliferation was analyzed by MTT assay and cell apoptosis was carried out by flow cytometry. CIA mice model was developed to evaluate the therapeutic efficacy of ginsenosides. The analysis of histology, immunohistochemistry, flow cytometry and cytokine detections of the joint tissues were performed to elucidate the action mechanisms of ginsenosides. RESULTS: All six ginsenosides showed good therapeutic effect on acute arthritis compared with the negative control group, Ginsenoside CK provided the most effective treatment ability. It could significantly inhibit the proliferation and promote the apoptosis of RAW 264.7 and HUVEC cells, and substantially reduce the swelling, redness, functional impairment of joints and the pathological changes of CIA mice. Meanwhile, CK could increase CD8 + T cell to down-regulate the immune response, decrease the number of activated CD4 + T cell and proinflammatory M1-macrophages, thus resulting in the inhibition of the secretion of proinflammatory cytokine such as TNF-α and IL-6. CONCLUSION: Ginsenoside CK was proved to be a most potential candidate among the tested ginsenosides for the treatment of RA, with a strong anti-inflammation and immune modulating capabilities. |
format | Online Article Text |
id | pubmed-8145820 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81458202021-05-25 Therapeutic effect of various ginsenosides on rheumatoid arthritis Zhang, Meng Ren, Hongwei Li, Kun Xie, Shengsheng Zhang, Ru Zhang, Longlong Xia, Jiaxuan Chen, Xing Li, Xilin Wang, Jianxin BMC Complement Med Ther Research Article BACKGROUND: Rheumatoid arthritis (RA) is an autoimmune disease which causes disability and threatens the health of humans. Therefore, it is of great significance to seek novel effective drugs for RA. It has been reported that various ginsenoside monomers are able to treat RA. However, it is still unclear which ginsenoside is the most effective and has the potential to be developed into an anti-RA drug. METHODS: The ginsenosides, including Rg1, Rg3, Rg5, Rb1, Rh2 and CK, were evaluated and compared for their therapeutic effect on RA. In in vitro cell studies, methotrexate (MTX) and 0.05% dimethyl sulfoxide (DMSO) was set as a positive control group and a negative control group, respectively. LPS-induced RAW264.7 cells and TNF-α-induced HUVEC cells were cultured with MTX, DMSO and six ginsenosides, respectively. Cell proliferation was analyzed by MTT assay and cell apoptosis was carried out by flow cytometry. CIA mice model was developed to evaluate the therapeutic efficacy of ginsenosides. The analysis of histology, immunohistochemistry, flow cytometry and cytokine detections of the joint tissues were performed to elucidate the action mechanisms of ginsenosides. RESULTS: All six ginsenosides showed good therapeutic effect on acute arthritis compared with the negative control group, Ginsenoside CK provided the most effective treatment ability. It could significantly inhibit the proliferation and promote the apoptosis of RAW 264.7 and HUVEC cells, and substantially reduce the swelling, redness, functional impairment of joints and the pathological changes of CIA mice. Meanwhile, CK could increase CD8 + T cell to down-regulate the immune response, decrease the number of activated CD4 + T cell and proinflammatory M1-macrophages, thus resulting in the inhibition of the secretion of proinflammatory cytokine such as TNF-α and IL-6. CONCLUSION: Ginsenoside CK was proved to be a most potential candidate among the tested ginsenosides for the treatment of RA, with a strong anti-inflammation and immune modulating capabilities. BioMed Central 2021-05-25 /pmc/articles/PMC8145820/ /pubmed/34034706 http://dx.doi.org/10.1186/s12906-021-03302-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Zhang, Meng Ren, Hongwei Li, Kun Xie, Shengsheng Zhang, Ru Zhang, Longlong Xia, Jiaxuan Chen, Xing Li, Xilin Wang, Jianxin Therapeutic effect of various ginsenosides on rheumatoid arthritis |
title | Therapeutic effect of various ginsenosides on rheumatoid arthritis |
title_full | Therapeutic effect of various ginsenosides on rheumatoid arthritis |
title_fullStr | Therapeutic effect of various ginsenosides on rheumatoid arthritis |
title_full_unstemmed | Therapeutic effect of various ginsenosides on rheumatoid arthritis |
title_short | Therapeutic effect of various ginsenosides on rheumatoid arthritis |
title_sort | therapeutic effect of various ginsenosides on rheumatoid arthritis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145820/ https://www.ncbi.nlm.nih.gov/pubmed/34034706 http://dx.doi.org/10.1186/s12906-021-03302-5 |
work_keys_str_mv | AT zhangmeng therapeuticeffectofvariousginsenosidesonrheumatoidarthritis AT renhongwei therapeuticeffectofvariousginsenosidesonrheumatoidarthritis AT likun therapeuticeffectofvariousginsenosidesonrheumatoidarthritis AT xieshengsheng therapeuticeffectofvariousginsenosidesonrheumatoidarthritis AT zhangru therapeuticeffectofvariousginsenosidesonrheumatoidarthritis AT zhanglonglong therapeuticeffectofvariousginsenosidesonrheumatoidarthritis AT xiajiaxuan therapeuticeffectofvariousginsenosidesonrheumatoidarthritis AT chenxing therapeuticeffectofvariousginsenosidesonrheumatoidarthritis AT lixilin therapeuticeffectofvariousginsenosidesonrheumatoidarthritis AT wangjianxin therapeuticeffectofvariousginsenosidesonrheumatoidarthritis |